Making Technology Accessible

Many zany and futuristic gadgets made their premiere at last week’s CES 2019. While much of the technology debuted at the show was geared toward luxury and progress, numerous cutting-edge innovations were designed specifically for people with disabilities. This change in direction exhibits the ways that the tech industry is shifting more focus on accessible technology so everyone can enjoy products on the market.

A fine model of this shift is a product from eSight. Read more >>

Dan Feinberg: A CES 2019 Preview

The Saturday before CES begins is a transition day here in Las Vegas. The weekend sports fans and partygoers are leaving, and floods of techies from around the world are pouring in. This afternoon, a number of the very first 2019 public relation gatherings—showing mostly startup companies—are open to the press. Read more >>

Corbus Pharmaceuticals Announces Strategic Collaboration with Kaken Pharmaceutical Co., Ltd. to Develop and Commercialize Lenabasum in Japan for Systemic Sclerosis and Dermatomyositis

Corbus Pharmaceuticals Holdings, Inc. announced today that they have entered into a strategic collaboration with Kaken Pharmaceutical Co., Ltd. (“Kaken”) for the development and commercialization in Japan of Corbus’ investigational drug lenabasum for the treatment of systemic sclerosis (“SSc”) and dermatomyositis (“DM”), two rare and serious autoimmune diseases. Read more >>